Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 529 results for "Victoza"

Novo Nordisks (NVO) Diabetes Drug Victoza Receives Positive Review By CHMP
Bidness Etc

Novo Nordisks (NVO) Diabetes Drug Victoza Receives Positive Re...

Novo Nordisks key drug Victoza has been backed by the European Medicines Agencys CHMP as a treatment for type 2 diabetes patients with moderate renal impairment Page 1 of 2 Click Ticker to See live coverage Novo Nordisk A/S (ADR) ( ... Bidness Etc, 1 day ago

2 images for "Victoza"

Bidness Etc, 1 day ago
Pharma Letter, 4 days ago

Novo Nordisk's Victoza Recommended for Label Expansion

Novo Nordisk A/S ( NVO ) announced that Victoza (once-daily) has received a positive opinion from The Committee for Medicinal Products for Human Use ( CHMP ) for the treatment of patients suffering from type II diabetes and moderate renal ...
 Yahoo! Finance1 day ago Novo finds new way to sell Tresiba in EU while awaiting another shot in U.S.  FiercePharma2 months ago

BRIEF-Novo'S victoza receives positive opinion for use in adults with type 2 diabetes

COPENHAGEN Nov 21 (Reuters) - Novo Nordisk A/S : ** Victoza receives positive Committee for Medicinal Products for Human Use opinion opinion for use in adults with type 2 diabetes and moderate renal impairment ** Once the European Commission ...
 Reuters UK4 days ago

Novo Nordisk Profit Rises 1% as Victoza Sales Beat Estimates

Novo Nordisk A/S (NOVOB) , the world's largest insulin maker, reported a 1 percent gain in third-quarter profit, helped by sales of insulins and the Victoza diabetes treatment. Net income climbed to 6.5 billion kroner ($1.1 billion) from 6.42 ...
 Bloomberg3 weeks ago Novo Nordisk Forecasts 2015 Operating Profit to Rise 10%  BusinessWeek3 weeks ago

Why Novo's Saxenda is not Victoza [Medical Marketing and Media]

[October 15, 2014] (Medical Marketing and Media Via Acquire Media NewsEdge) AN FDA ADVISORY panel said last month that the regula- tor should greenlight an obesity indication for Novo Nordisk's GLP-1 liraglutide, with a vote of ...
 TMC Net1 month ago

Novo Nordisk Injection Receives Backing from FDA Panel

A panel of Food and Drug Administration advisors has voted to approve the use of Novo Nordisk's diabetes drug Victoza for a new indication. The panel voted 14-1 to approve the drug to be used in patients who are obese or dangerously overweight.
 MedIndia2 months ago Novo coy on Victoza weight loss filing  Pharma In Focus2 months ago Janssen Is Working Its Way Toward Anti-Obesity  Seeking Alpha1 week ago FDA panel backs liraglutide for obesity  Drugtopics.com1 month ago

Novo Nordisk increased operating profit in local currencies by 11% in the first nine months of 2014

8% sales growth in local currencies driven by Levemir ® and Victoza ® Sales increased by 8% in local currencies and by 4% in Danish kroner to DKK 64.2 billion during the first nine months of 2014 compared to the same period in 2013. Sales of ...
 EuroInvestor3 weeks ago REG-Novo Nordisk increased operating profit in local currencies by 11% in the first nine months of 2014  Reuters3 weeks ago

Will GLP market growth save Novo's Victoza from Lilly's new Trulicity?

When a new drug bursts upon an established drug class, the established players often wave away worries about market share. Sales for the whole class will grow, they say, because we'll have one more company on the street promoting it. Sometimes ...
 FiercePharma1 week ago NOVO NORDISK A/S : Why Novo's Saxenda is not Victoza  4 Traders1 month ago Dane in America  Pharmaceutical Executive2 weeks ago Novo Nordisk Braves the Obesity Market  Corante3 weeks ago

ViewPoints: Eli Lilly chooses not to compete with Victoza on list price, but discounting trends may tell a different story

You attempted to read ViewPoints , exclusive content for FirstWord Pharma PLUS members. You currently are not registered for any FirstWord Pharma services. To gain instant access to ViewPoints plus additional enhanced content and features, please ...
 FirstWord Pharma2 months ago

Novo Nordisk wins EU approval for a diabetes combo with billion-dollar potential

Novo Nordisk ($NVO) picked up European approval for a combination of a long-acting insulin and its own Victoza, pioneering a once-a-day approach to Type 2 diabetes that could bring in blockbuster sales. The drug pairs Tresiba, an insulin analog ...
 FierceBiotech2 months ago EU approval for Novo Nordisk's diabetes combo  Pharma Field2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less